Testing Multiple Drugs in One Trial: UK Launches Alzheimer’s Drug Repurposing Study
AD-SMART has recruited its first participants and will initially test metformin and atomoxetine. By sharing a placebo group and using interim analyses, the team hopes to shorten the wait for effective treatments, but whether either drug can improve patients’ lives remains for clinical results to answer.